~~<i id='F32599A63B'><strike id='F32599A63B'><tt id='F32599A63B'><pre id='F32599A63B'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

author：explore 2025-09-30 04:11:01 Page View：47

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump Jan. 6 attorney John Lauro is ex
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

Alabama IVF ruling threatens families facing fatal genetic disease

Henrywithhisparents.Illustration:STAT;Courtesy:AllenGoldbergWhenmywife,Laurie,completedherninthinvit

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

The Harvard botanist who searched for psychedelics in the Amazon

RichardEvansSchultesintheCerroCampanamountainsinColombia,inJune1943.TheEstateofRichardEvansSchultes/